THRM

AI Memo

Gentherm

As of 2026-09-02/Confidence high/Horizon 6‑12m

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-09-02 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

high

Horizon

6‑12m

Key catalyst

Q2 record revenue and raised FY2026 guidance • 2026-07-23

Base target: $43 / p=55% prob

Biggest risk

Gross-margin compression, sharply lower operating cash flow, warranty and material-cost pressure, and the need to execute a strategic transaction temper the outlook. Current guidance depends on tariffs, customer orders, vehicle production, and other assumptions, while the Modine combination is not included.

Invalidation

Break below $32 or thesis failure.

What would change my mind?

Record Q2 revenue, strong Automotive Climate and Comfort Solutions growth, $690 million of automotive new-business awards, and raised FY2026 guidance support a cautiously positive operating thesis. The Modine transaction and expanded repurchase authorization add potential strategic and capital-allocation upside.

Research note

Recommendation

—

Confidence

high

As of

2026-09-02

Base target

$43

p=55%

Bull target

$50

p=25%

Bear target

$32

p=20%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Margin and cash-flow proof after Q2
Planned Modine Performance Technologies combination
New $400 million share-repurchase authorization

BearKey bullets

FY2026 guidance assumes current tariffs, customer-order expectations, light-vehicle production trends, and a specified EUR/USD exchange rate.
Gross-margin pressure from material costs and higher warranty accruals.
Medical acquisition integration and realization of cross-selling opportunities remain unproven.

WatchKey bullets

Q2 record revenue and raised FY2026 guidance

Summary

High-level snapshot

Recommendation

Model confidence

high

Timeframe

6‑12m

Asset

Equity

Trigger

Base case: $43 (p=55%)

Target spread vs base: +16% / -26%

Scenario probabilities

Bull Target: $50 (p=25%)Base Target: $43 (p=55%)Bear Target: $32 (p=20%)

Commentary

Primary SEC earnings materials are materially positive on revenue, automotive growth, guidance, new-business awards, and capital allocation. However, analyst revisions, post-print price-reaction attribution, social sentiment, options skew, short interest, and employee sentiment are unavailable; missing fields are not treated as neutral evidence. The appropriate stance is cautious monitoring rather than a high-conviction rerating thesis. [#SEC-8K-2026-07-23]

As of 2026-09-02 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Margin and cash-flow proof after Q2
Planned Modine Performance Technologies combination
New $400 million share-repurchase authorization

Scenarios

Bull Target (Scenario probability)

$50 / p=25% prob

Base Target (Scenario probability)

$43 / p=55% prob

Bear Target (Scenario probability)

$32 / p=20% prob

Analysis 2026-09-02 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.65

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-07-23
Q2 record revenue and raised FY2026 guidance
Gentherm reported record quarterly revenue of $416.2 million, 11.0% year over year, and raised FY2026 product-revenue guidance to $1.55-$1.65 billion and adjusted EBITDA guidance to $185-$200 million. Automotive Climate and Comfort Solutions revenue increased 14.1%. [#SEC-8K-2026-07-23]
Prob 90.00% • Move 7.00% • Priced-in 85.00%

Short-term Catalysts

Next few weeks

Margin and cash-flow proof after Q2
2026-12-01
Gross margin declined to 23.2% from 23.9%, while operating cash flow fell to $2.3 million from $31.7 million, with higher material, warranty, restructuring, and M&A costs cited as pressures. Near-term performance depends on converting growth into stronger margins and cash flow. [#SEC-8K-2026-07-23]
Prob 55% • Move -6% • Priced-in 40%

Long-term Catalysts

Months to a year

Planned Modine Performance Technologies combination
2027-09-02
The company said key sign-to-close deliverables were completed and the planned combination remains on track to close by early Q4 2026. The transaction is excluded from current FY2026 guidance, leaving potential upside but also execution risk. [#SEC-8K-2026-07-23]
Prob 65% • Move 10% • Priced-in 55%
New $400 million share-repurchase authorization
2027-09-02
The board authorized up to $400 million of repurchases through July 27, 2029, replacing the prior program. Execution is discretionary and subject to capital needs, market conditions, debt covenants, and other restrictions. [#SEC-8K-2026-07-23]
Prob 65% • Move 4% • Priced-in 75%

Risks

FY2026 guidance assumes current tariffs, customer-order expectations, light-vehicle production trends, and a specified EUR/USD exchange rate.
Gross-margin pressure from material costs and higher warranty accruals.
Medical acquisition integration and realization of cross-selling opportunities remain unproven.
Operating cash flow declined materially year over year, partly due to restructuring and M&A expenses.
The planned Modine Performance Technologies combination carries timing and execution risk and is excluded from FY2026 guidance.

Peers

Symbol	Summary
ADNT	More direct auto-component comparator for vehicle production, customer demand, and manufacturing-margin cyclicality; Gentherm has more specialized thermal-comfort exposure.
XPEL	Adjacent auto-component comparator for execution and growth-driven rerating, but operating overlap with Gentherm is limited.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-09-02

Loading AI feed…

Symbol

Summary

ADNT

More direct auto-component comparator for vehicle production, customer demand, and manufacturing-margin cyclicality; Gentherm has more specialized thermal-comfort exposure.

XPEL

Adjacent auto-component comparator for execution and growth-driven rerating, but operating overlap with Gentherm is limited.